ADC	antibody-drug conjugate
BMI	body mass index
ER	estrogen receptor
ISH	in situ hybridization
HER2	human epidermal growth factor receptor 2
IHC	immunohistochemistry
NAC	neoadjuvant chemotherapy
NAT	neoadjuvant therapy
NET	neoadjuvant endocrine therapy
pCR	pathological complete response
PR	progesterone receptor
TIL	tumor stromal infiltrating lymphocytes